Prognostic Value of Plasma MR-proADM vs NT-proBNP for Heart Failure in People With Type 2 Diabetes: The SURDIAGENE Prospective Study

Diabetologia - Germany
doi 10.1007/s00125-018-4727-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Value of NT-proBNP in Patients With Severe COVID-19

Respiratory Research
PulmonaryRespiratory Medicine
2020English

Prognostic Value of NT-proBNP in Patients With Severe COVID-19

2020English

To Evaluate the Efficacy of Heart Failure Reversal Therapy Using NT-Probnp Levels in Patients With Chronic Heart Failure

Cardiology and Cardiovascular Research
2018English

NT-proBNP Assay Can Effectively Rule Out Heart Failure

BMJ
2002English

Increased Serum Elabela Level Related to NT-proBNP in Patients With Heart Failure

e-Journal of Cardiovascular Medicine
2020English

Racial Differences in the Association of NT-proBNP With Risk of Incident Heart Failure in REGARDS

JCI insight
Medicine
2019English

Prognosis and NT-proBNP in Heart Failure Patients With Preserved Versus Reduced Ejection Fraction

Heart
Cardiovascular MedicineCardiology
2019English

Prognostic Value of Plasma Neutrophil Gelatinase-Associated Lipocalin for Mortality in Patients With Heart Failure

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2014English

Longitudinal Evaluation of Ventricular Ejection Fraction and NT-proBNP Across Heart Failure Subgroups

Scandinavian Cardiovascular Journal
MedicineCardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy